These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4358483)

  • 21. [Vaso-active substances and pulmonary circulation].
    Campan L
    Ann Anesthesiol Fr; 1975; 16 Spec No 2-3():33-40. PubMed ID: 9869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic activity of the lung and its role in pulmonary disease.
    Said SI
    Clin Notes Respir Dis; 1971; 10(3):3-9. PubMed ID: 4943488
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolism of angiotensin and bradykinin in rat isolated lungs during the oestrous cycle [proceedings].
    Bakhle YS; Ben-Harari RR
    J Physiol; 1979 Jul; 292():38P-39P. PubMed ID: 573791
    [No Abstract]   [Full Text] [Related]  

  • 24. Metabolism of vasoactive agents in lung.
    Junod AF
    Am Rev Respir Dis; 1977 Jun; 115(6 Pt 2):51-7. PubMed ID: 194509
    [No Abstract]   [Full Text] [Related]  

  • 25. The surgical implications of nonrespiratory lung function.
    Addonizio VP; Harken AH
    J Surg Res; 1980 Jan; 28(1):86-95. PubMed ID: 6153737
    [No Abstract]   [Full Text] [Related]  

  • 26. The release and fate of vaso-active hormones in the circulation.
    Vane JR
    Br J Pharmacol; 1969 Feb; 35(2):209-42. PubMed ID: 4388134
    [No Abstract]   [Full Text] [Related]  

  • 27. [Role of the lungs in the metabolism of vasoactive substances].
    Tishkin OG; Temur'iants NA
    Fiziol Zh (1978); 1982; 28(1):82-5. PubMed ID: 7035226
    [No Abstract]   [Full Text] [Related]  

  • 28. Metabolism of vasoactive hormones by lung.
    Gillis CN
    Anesthesiology; 1973 Dec; 39(6):626-32. PubMed ID: 4148583
    [No Abstract]   [Full Text] [Related]  

  • 29. Pulmonary fate of vasoactive peptides in fetal, newborn, and adult sheep.
    Hébert F; Fouron JC; Boileau JC; Biron P
    Am J Physiol; 1972 Jul; 223(1):20-3. PubMed ID: 4339004
    [No Abstract]   [Full Text] [Related]  

  • 30. Metabolic functions of the pulmonary vascular endothelium.
    Ryan JW; Ryan US
    Adv Vet Sci Comp Med; 1982; 26():79-98. PubMed ID: 6758543
    [No Abstract]   [Full Text] [Related]  

  • 31. [Various metabolic, non-respiratory aspects of the lung].
    van Bronswijk H
    Ned Tijdschr Geneeskd; 1980 Oct; 124(43):1831-4. PubMed ID: 7442834
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of the lungs in the metabolism of circulating hormones.
    Stewart JM
    Chest; 1971 May; 59():Suppl:7S-8S. PubMed ID: 4396931
    [No Abstract]   [Full Text] [Related]  

  • 33. Alteration by kallikrein and bradykinin of the conversion of angiotensin I to angiotensin II in the isolated perfused rat lung.
    Ercan ZS; Bor NM; Torunoğlu M; Türker RK
    Arzneimittelforschung; 1982; 32(1):30-1. PubMed ID: 6174131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions between prostaglandins, leukotrienes and other mediators of inflammation.
    Williams TJ
    Br Med Bull; 1983 Jul; 39(3):239-42. PubMed ID: 6354350
    [No Abstract]   [Full Text] [Related]  

  • 36. Pinocytotic vesicles of the pulmonary endothelial cell.
    Smith U; Ryan JW
    Chest; 1971 May; 59():Suppl:12S+. PubMed ID: 4325032
    [No Abstract]   [Full Text] [Related]  

  • 37. Participation of endogenous vasoactive agents in the pathogenesis of endotoxin shock.
    Emerson TE
    Adv Exp Med Biol; 1971 Oct; 23(0):25-45. PubMed ID: 4137099
    [No Abstract]   [Full Text] [Related]  

  • 38. Intrarenal vasodilator systems: NO, prostaglandins and bradykinin. An integrative approach.
    Sadowski J; Badzynska B
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():105-19. PubMed ID: 19261975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The lung--an endocrine organ.
    Kahn A
    J Ark Med Soc; 1978 Apr; 74(11):462-3. PubMed ID: 148452
    [No Abstract]   [Full Text] [Related]  

  • 40. Metabolism of vasoactive substances in the lung: Change of metabolism and its significance in rabbits with experimental pneumonitis.
    Ueda E; Nishimura K; Nagasaka Y; Kokubu T; Yamamura Y
    Jpn Circ J; 1975 May; 39(5):559-63. PubMed ID: 239259
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.